This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Coca-Cola Company’s strong brand equity, marketing, research and innovation help it to garner a market share of more than 40% in the non-alcoholic beverage industry. The company is putting its best foot forward to evolve its business model to become a total beverage company with something for everyone to drink. The company has coped up with the industry-wide flattening of soda sales over the years by going on a buying spree and making investments in healthier alternatives like coffee, sparkling water and sports drinks. The roll out of Coca-Cola Energy, Coca-Cola Plus Coffee, Powerade Ultra and Powerade Power Water are some notable additions on these lines.
The Zacks Analyst Blog Highlights: Apple, American Express and Coca Cola
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, American Express and Coca Cola
Follow in Buffett's Footsteps Retaining 3 Payment Stocks
by Sapna Bagaria
Growing digital payments and e-commerce hold the payment processing stocks in good stead.
Consumer Staples ETF (VDC) Hits New 52-Week High
by Sweta Killa
This consumer staples ETF hits a new 52-week high. Are more gains in store for this ETF?
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Boston Beer (SAM), PepsiCo (PEP) to Launch Hard Mountain Dew
by Zacks Equity Research
Boston Beer (SAM) and PepsiCo (PEP) plans to launch the Hard Mountain Dew alcoholic beverage, marking PepsiCo's venture into the alcoholic beverage space.
Monster Beverage (MNST) Q2 Earnings & Sales Beat, Costs Hurt
by Zacks Equity Research
Monster Beverage (MNST) reports strong Q2 results despite headwinds from shortages in aluminum can supplies, global port congestion, and higher input and freight costs.
PepsiCo (PEP) Agrees to Offload Its Juice Brands to PAI
by Zacks Equity Research
PepsiCo (PEP) unveils plans to offload juice businesses, including Tropicana, to PAI for $3.3 billion. The deal will help it focus on expanding on-trend brands and expand margins.
Clorox (CLX) Dips on Q4 Earnings & Sales Miss, Gives FY22 View
by Zacks Equity Research
Lower shipments from the last year's peak, unfavorable price mix, and higher operating and commodity costs mar Clorox's (CLX) Q4 results. It outlines the view for fiscal 2022.
Keurig Dr Pepper (KDP) Tops on Q2 Earnings & Sales, Hikes View
by Zacks Equity Research
Keurig Dr Pepper (KDP) sees robust business trends across segments in Q2 due to increased consumer mobility, which translates into improved away-from-home channel sales. It raises 2021 sales view.
FEMSA (FMX) Q2 Earnings Miss, Rise Y/Y on Recovered Trends
by Zacks Equity Research
Recovery across markets and business units, as consumers return to stores, aid FEMSA (FMX) in Q2. The company reports strong y/y comparisons across all units.
AB InBev (BUD) Q2 Earnings & Revenues Lag Estimates, Rise Y/Y
by Zacks Equity Research
AB InBev (BUD) witnesses strong momentum in Q2, with earnings and revenues improving year over year. Revenues also increase from the pre-pandemic levels.
The Zacks Analyst Blog Highlights: Comcast, Coca-Cola, Bristol-Myers Squibb, Cisco Systems and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Coca-Cola, Bristol-Myers Squibb, Cisco Systems and Stryker
Top Analyst Reports for Comcast, Coca-Cola & Bristol-Myers Squibb
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), The Coca-Cola Company (KO), and Bristol-Myers Squibb (BMY).
Upbeat Coca-Cola Earnings Boosts These ETFs
by Sanghamitra Saha
The Coca-Cola Company has delivered second-quarter 2021 results, wherein earnings and sales beat the Zacks Consensus Estimate and improved year over year.
Stock Market News for Jul 22, 2021
by Zacks Equity Research
U.S. stocks closed higher for the second successive day on Wednesday, as a string of upbeat earnings coupled with renewed optimism about the nation's economic recovery gave a boost to investors' confidence.
Coke, J&J, Verizon All Beat on Q2 Numbers
by Mark Vickery
Today's pre-market trading activity appears to have reverted back to the sector rotation between growth/tech names and cyclical/value stocks.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge
Coca-Cola (KO) Tops Q2 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Coca-Cola (KO) witnesses positive revenue trends in Q2, owing to ongoing recovery across most markets due to the subsiding of the pandemic-led headwinds. It raises the 2021 view.
Coca-Cola (KO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Coke (KO) delivered earnings and revenue surprises of 19.30% and 6.74%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Buy SAM Stock Down 25% Before Q2 Earnings?
by Benjamin Rains
The Boston Beer Company, Inc. (SAM) has tumbled since its Q1 release in April, as Wall Street sold overheated shares and questioned how much longer the seltzer craze will last...
A Big Week for Earnings: Global Week Ahead
by John Blank
In the Global Week Ahead, earnings reports move away from the major banks, into more interesting cyclical industry niches.
Coca-Cola (KO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Coca-Cola (KO) closed at $56.44 in the latest trading session, marking a +0.32% move from the prior day.
Things You Must Know Ahead of Coca-Cola's (KO) Q2 Earnings
by Zacks Equity Research
Coca-Cola (KO) is expected to have seen continued gains from the off-premise channel, strong volumes, improved price/mix and costs management initiatives in Q2. Headwinds in on-premise to have remained.
Stock Market News for Jul 15, 2021
by Zacks Equity Research
U.S. stock markets closed mostly higher on Wednesday after the U.S. Federal Reserve Chair assured that the Fed will maintain its easy monetary policy.
Coca-Cola (KO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Coke (KO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.